Business Context and Reporting Period
This Form 8-K, dated October 8, 2020 and signed October 9, 2020, reports the completion of the business combination between Churchill Capital Corp III and MultiPlan Parent Corp. The combined company was renamed MultiPlan Corporation and became the successor to Churchill. The filing describes MultiPlan as a provider of healthcare data analytics and technology-enabled cost-management solutions.
The filing text identifies the registrant as MultiPlan Corporation; it does not reference Claritev Corp.
Key Financial Metrics and Capitalization
- Public-share redemptions totaled 8,693,855 shares at approximately $10.03 per share, or $87.2 million in aggregate.
- Approximately $1,015.9 million remained in Churchill’s trust account immediately before closing and was used to fund the business combination.
- Former indirect owners of MultiPlan Parent received 415.7 million shares of Class A common stock.
- The common PIPE investment issued 132.05 million shares and warrants to purchase 6.5 million shares for gross proceeds of $1.3 billion.
- The convertible PIPE issued $1.3 billion principal amount of 6.00%/7.00% Convertible Senior PIK Toggle Notes due 2027 for gross proceeds of $1,267.5 million.
- The Convertible Notes bear 6.00% annual cash interest or 7.00% PIK interest, at the Company’s election, and mature October 15, 2027. They initially convert at approximately $13.00 per share.
- All $1,178.7 million of Polaris Intermediate’s outstanding 8.500%/9.250% Senior PIK Toggle Notes due 2022 were redeemed and discharged at closing.
- The filing states that 667,461,269 Class A shares were outstanding after closing, excluding 9,094,876 treasury shares. A separate Item 3.02 disclosure states 676,556,145 shares outstanding; investors should reconcile this apparent inconsistency.
- The filing provides historical and pro forma financial statements by incorporation and exhibit, but the supplied text does not provide clear revenue, net income, operating margin, cash-flow, liquidity, or total-debt figures for the comparable periods.
Material Changes Versus the Prior Comparable Period
- Churchill changed from a special-purpose acquisition company to an operating company and ceased being a shell company.
- MultiPlan Parent became the operating business owned through the combined company.
- The Company incurred $1.3 billion of new Convertible Notes while retiring $1.1787 billion of Senior PIK Notes due 2022.
- The transaction materially increased the authorized capital stock to 1.51 billion shares, including 1.5 billion authorized Class A common shares and 10 million preferred shares.
- Class A common stock and warrants were scheduled to begin trading on the NYSE under MPLN and MPLN.WS on October 9, 2020, subject to continued satisfaction of listing requirements.
- Former owners of Holdings beneficially owned approximately 62% of the outstanding common stock following closing.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- The filing does not provide formal financial guidance or quantitative operating forecasts.
- Management’s forward-looking statements concern expected transaction benefits, growth, profitability, liquidity, strategic execution, and operating efficiencies, but no specific targets are provided in the supplied text.
- Material risks include customer concentration and customer payment ability, pricing pressure, competition, provider relationships and discounts, healthcare regulation, alleged fee-splitting or corporate-practice-of-medicine issues, cybersecurity and privacy risks, integration and acquisition execution, leverage and the ability to service debt, internal-control weaknesses, COVID-19 impacts, litigation, and NYSE listing compliance.
- Five stockholder actions were filed in connection with the business combination. Three were voluntarily dismissed; the remaining actions generally alleged proxy disclosure and fiduciary-duty violations and sought injunctive relief and attorneys’ fees and expenses.
- The Board dismissed Marcum LLP and appointed PwC as independent registered public accounting firm. Marcum’s predecessor-company report had included a going-concern explanatory paragraph, but the filing reports no disagreements or reportable events with Marcum.
- The Company paid $2.2 million at closing to P. Galant & Associates, an affiliate of executive officer Paul Galant, and paid the placement fee owed to The Klein Group in cash. The Klein Group and affiliates also undertook a $15.0 million post-closing share-purchase commitment.
- The Company adopted a classified board structure, supermajority voting provisions in specified circumstances, exclusive forum provisions, and other provisions that may deter or delay changes in control.
Most Important Facts for Investors to Verify
- Reconcile the conflicting post-closing share counts of 667,461,269 and 676,556,145.
- Review Exhibits 99.3–99.9 for MultiPlan’s historical financial statements, Churchill’s financial statements, and pro forma combined results, including revenue, earnings, cash flow, margins, and debt.
- Assess the Convertible Notes’ cash-versus-PIK interest election, conversion terms, redemption provisions, and potential dilution.
- Confirm the final debt structure after redemption of the Senior PIK Notes and issuance of the Convertible Notes.
- Review the remaining stockholder litigation and transaction-related fees and contingencies.
- Confirm continued NYSE listing compliance and the commencement of trading under MPLN and MPLN.WS.